CareDx (CDNA) Tops Q3 EPS by 36c, Beats on Revenue; Offers FY25 Revenue Guidance

CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.28, $0.36 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.1 million versus the consensus estimate of $95.32 million.

GUIDANCE:

CareDx sees FY2025 revenue of $372-376 million, versus the consensus of $368.9 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• argenx SE (ARGX) PT Raised to $1,115 at Leerink
• INVO Fertility (IVF) Tops Q2 EPS by 105c